Related Experiment Video

Updated: Aug 14, 2026

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation
09:43

Primary Orthotopic Glioma Xenografts Recapitulate Infiltrative Growth and Isocitrate Dehydrogenase I Mutation

Published on: January 14, 2014

Glycogen-rich meningioma. Case report and short review

K Shiraishi1

  • 1Department of Neurosurgery, Hanyu Hospital, Saitama, Japan.

Neurosurgical Review
|January 1, 1991
PubMed

Insights

This study describes an atypical meningioma characterized by cytoplasm abundant in glycogen granules. This finding contributes to understanding rare meningioma subtypes.

Area of Science:

  • Neuropathology
  • Oncology

Background:

  • Meningiomas are tumors arising from the meninges.
  • Meningotheliomatous meningioma is a common subtype.
  • Atypical meningiomas exhibit specific histological features.

Observation:

  • A specific case of meningioma exhibited cytoplasm unusually rich in glycogen granules.
  • This histological feature suggested an atypical variant.

Findings:

  • The observed case was classified as an atypical meningotheliomatous meningioma.
  • The presence of abundant glycogen granules is a key distinguishing feature.

Implications:

  • This case expands the known histological spectrum of meningiomas.
  • Understanding glycogen-rich variants may refine diagnostic criteria.
  • Further research into the pathobiology of these variants is warranted.

More Related Videos

Detecting Glycogen in Peripheral Blood Mononuclear Cells with Periodic Acid Schiff Staining09:42

Detecting Glycogen in Peripheral Blood Mononuclear Cells with Periodic Acid Schiff Staining

Published on: December 23, 2014

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)08:46

A Protocol for Rapid Post-mortem Cell Culture of Diffuse Intrinsic Pontine Glioma (DIPG)

Published on: March 7, 2017

Related Concept Videos

Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...